All In Biotech

Drug Trial Radar · NCT02932150

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects With Chronic Hepatitis B Virus Infection

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Nov 2016

Primary completion

Oct 27, 2026

Study completion Oct 2029

Sponsor

Lead sponsor
Gilead SciencesGilead Sciences (GILD)
Sponsor type
Industry
First posted
Oct 13, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with CHB and to learn more about the dosing levels in children.

Conditions

  • Chronic Hepatitis B

Interventions

  • TAFDrug

    Administered orally once daily

  • PlaceboDrug

    Administered orally once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-Emergent Serious Adverse Events (SAEs) at Week 24Time frame: Week 24
  2. Incidence of Treatment-Emergent Adverse Events (AEs) at Week 24Time frame: Week 24
  3. Percentage of participants with plasma HBV DNA < 20 IU/mL at Week 24Time frame: Week 24
  4. PK Parameter: AUCtau of TAF for participants from Cohort 2 Part ATime frame: Predose, 15 minutes, 30 minutes, 1, 1.5, 2, 3, 4, 5, and 8 hours postdose at Week 4 or 8 or 12

Locations

39 sites in 8 countries. Site status is shown where the registry gives one.

  • Children's Hospital of Los Angeles

    Los Angeles, California

  • Rady Childrens Hospital

    San Diego, California

  • University of California, San Francisco (UCSF)

    San Francisco, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Indiana University School of Medicine

    Indianapolis, Indiana

  • Johns Hopkins University

    Baltimore, Maryland

  • Children's Mercy Hospital

    Kansas City, Missouri

  • The Children's Hospital at Montefiore

    The Bronx, New York

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Nationwide Children's Hospital

    Columbus, Ohio

  • Monroe Carell Jr. Children's Hospital at Vanderbilt

    Nashville, Tennessee

  • Cook Children's Medical Center

    Fort Worth, Texas

  • Texas Children's Hospital - Main Hospital

    Houston, Texas

  • American Research Corporation at Texas Liver Institute

    San Antonio, Texas

  • Seattle Children's Hospital

    Seattle, Washington

  • Cliniques Universitaires Saint-LUC UCL

    Brussels, Belgium

  • Prince of Wales Hospital

    Shatin, Hong Kong

  • Institute of Post Graduation Medical Education & Research

    Kolkata, India

  • M. V Hospital and Research Center

    Lucknow, India

  • Seth GS Medical College and KEM Hospital

    Mumbai, India

  • LTMMC & LTMG Hospital

    Mumbai, India

  • Khalatkar Hospital

    Nagpur, India

  • All India Institute of Medical Sciences

    New Delhi, India

  • SIDS Hospital and Research Centre

    Surat, India

  • Samvedna Hospital

    Varanasi, India

  • Spitalul Grigore Alexandrescu-Sectia Pediatrie III

    Bucharest, Romania

  • Institutul National de Boli Infectioase "Prof.Dr. Matei Bals"

    Bucharest, Romania

  • Federal Research Centre of Nutrition, Biotechnology and Food Safety

    Moscow, Russia

  • Federal State-Financed Institution Pediatric Research and Clinical Center for Infectious Diseases

    Saint Petersburg, Russia

  • Republican Clinical Hospital of Infectious Diseases named after A.F. Agafonov

    Tatarstan, Russia

  • Limited Medical Company Hepatolog

    Tolyatti, Russia

  • Kyungpook National University Hospital

    Daegu, South Korea

  • Asan Medical Center

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    Kaohsiung City, Taiwan

  • Chang Gung Medical Foundation, Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, Taiwan

  • National Cheng Kung University Hospital

    Tainan, Taiwan

  • National Taiwan University Hospital

    Taipei, Taiwan

  • Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou

    Taoyuan, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.